16.15
-0.26(-1.58%)
Currency In USD
| Previous Close | 16.41 |
| Open | 16.35 |
| Day High | 16.74 |
| Day Low | 16.01 |
| 52-Week High | 18.67 |
| 52-Week Low | 5.32 |
| Volume | 18,291 |
| Average Volume | 126,830 |
| Market Cap | 105.86M |
| PE | -9.12 |
| EPS | -1.77 |
| Moving Average 50 Days | 14.59 |
| Moving Average 200 Days | 9.02 |
| Change | -0.26 |
If you invested $1000 in electroCore, Inc. (ECOR) since IPO date, it would be worth $54.24 as of February 05, 2025 at a share price of $16.15. Whereas If you bought $1000 worth of electroCore, Inc. (ECOR) shares 5 years ago, it would be worth $861.33 as of February 05, 2025 at a share price of $16.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Di
electroCore Expands Intellectual Property Portfolio
GlobeNewswire Inc.
Jan 07, 2025 1:00 PM GMT
electroCore Granted Five New U.S. PatentsROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received five patent issue noti
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
GlobeNewswire Inc.
Dec 17, 2024 9:05 PM GMT
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at 4:30 p.m. EST ROCKAWAY, N.J., Dec. 17, 2024 (GLOBE N